CUSIP 29664W105COMESPRQ4 2025
73 filings · latest Nov 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 17.68M | $65.42M |
| 2 | Vanguard Group Inc | 14.95M | $55.30M |
| 3 | Two Seas Capital LP | 11.90M | $44.04M |
| 4 | Wasatch Advisors LP | 9.45M | $34.95M |
| 5 | D. E. Shaw & Co., Inc. | 6.90M | $25.54M |
| 6 | Orbimed Advisors LLC | 5.97M | $22.07M |
| 7 | State Street Corp | 5.93M | $21.94M |
| 8 | Geode Capital Management, LLC | 5.74M | $21.23M |
| 9 | Marshall Wace, LLP |
| 4 | Apr 7, 2025 | Wasatch Advisors LP | 13G/A | 5.5% | 10.93M | SEC |
| 5 | Mar 10, 2025 | Bb Biotech AG | 13G/A | 4.9% | 9.69M | SEC |
| 6 | Feb 14, 2025 | Bb Biotech AG | 13G/A | 5.0% | 9.94M | SEC |
| 7 | Nov 14, 2024 | Two Seas Capital LP | 13G/A | 3.3% | 6.58M | SEC |
| 8 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 6.6% | 13.04M | SEC |
| 9 | Nov 8, 2024 | Blackrock, Inc. | 13G | 7.3% | 14.27M | SEC |
| 10 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 6.6% | 13.04M | SEC |
See the full Schedule 13D/13G history for Esperion Therapeutics Inc Ne.
Unlock full history| 5.47M |
| $20.24M |
| 10 | Two Sigma Investments, LP | 4.74M | $17.55M |